Artecanin

Catalog No. :
ACQHNT823
CAS No. :
29431-84-3
Molecular Formula :
C15H18O5
Molecular Weight :
278.30

IUPAC Name:(1aS,2R,4aS,7aS,7bS,7cR,8aS,8bR)-2-hydroxy-2,7c-dimethyl-5-methyleneoctahydro-2H-bis(oxireno)[2',3':1,8a;2'',3'':2,3]azuleno[4,5-b]furan-6(5H)-one

Artecanin structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameArtecanin
IUPAC Name(1aS,2R,4aS,7aS,7bS,7cR,8aS,8bR)-2-hydroxy-2,7c-dimethyl-5-methyleneoctahydro-2H-bis(oxireno)[2',3':1,8a;2'',3'':2,3]azuleno[4,5-b]furan-6(5H)-one
Molecular FormulaC15H18O5
Molecular Weight278.30
SMILESO=C(O[C@@]1([H])[C@@]2([H])CC[C@@](C)(O)[C@@]34[C@@](O4)([H])[C@@](O5)([H])[C@@]5(C)[C@@]31[H])C2=C
InChI KeyKXLUWEYBZBGJRZ-SSISGLGMSA-N
Synonym(3aS,6aS)-3aβ,5,6,7aβ,7bβ,8a,8bβ,8cβ-Octahydro-6β-hydroxy-6,8aβ-dimethyl-3-methylene-4H-bisoxireno[1,8a:2,3]azuleno[4,5-b]furan-2(3H)-one;Chrysartemin B;(3aS,6aS,7aβ,7bβ,8bβ,8cα)-3a,5,6,7a,7b,8a,8b,8c-Octahydro-6β-hydroxy-6,8aβ-dimethyl-3-methylene-4H-bisoxireno[1,8a:2,3]azuleno[4,5-b]furan-2(3H)-one;Artecanin;4H-Bisoxireno[1,8a:2,3]azuleno[4,5-b]furan-2(3H)-one, octahydro-6-hydroxy-6,8a-dimethyl-3-methylene-, (3aS,6R,6aS,7aR,7bS,8aR,8bS,8cS)-
CAS No.29431-84-3

Synthetic Route by SureRoute

1. ACQHNT823 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQHNT823 route product structure diagram
    ACQHNT82329431-84-3
Inquiry

2. ACQHNT823 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQHNT823 route product structure diagram
    ACQHNT82329431-84-3
Inquiry

Comments (0)